Home - Arbidyne

An absolute return fund that focuses on delivering strong risk-adjusted returns in most market conditions.

Finding the intersection between value and momentum

Equipped with the knowledge, experience and proven track record, Arbidyne has partnered with Gleneagle Securities (trading as FXTRADING.com) to bring hedge-fund trading to the retail investor.

MAFT Strategy

The MAFT strategy is a proprietary trading framework developed by Arbidyne Capital to identify high probability trades with minimum downside risks.

Risk Management

Products traded include foreign and domestic stocks, foreign and domestic stock index futures, bond futures, currencies, exchange traded funds, commodities and options over all of those products.

Fund Performance

Arbidyne strive to outperform the market with cumulative and steady returns. Yet that does not mean the risk management process must cap upside potential.

Investment Summary

Arbidyne aims to outperform the markets under most trading conditions with portfolio diversification whilst retaining a low correlation to equity markets.

Start your investment journey in two easy steps

Step 1

Carefully read the Product
Disclosure Statement

Step 2

Fill out the application form

Step 3

Transfer your funds

Arbidyne Pty Ltd is a Corporate Authorised Representative (ASIC CAR No 1291963) of Gleneagle Asset Management Limited, AFSL No 226199. Arbidyne Managed Account Service is an ASIC Registered Managed Investment Scheme ARSN 110 295 755 (currently with the registered name “Managed Accounts Service”).

Any advice included in this website or correspondence is general advice only and is based solely on consideration of the investment or trading merits of the financial products alone, without taking into account the investment objectives, financial situation and particular needs (i.e. financial circumstances) of any particular person. Before making an investment or trading decision based on the advice, the recipient should carefully consider the appropriateness of advice in light of his or her financial circumstances and should carefully review the Product Disclosure Statement regarding the relevant financial product as provided by your investment broker. Investing in over-the-counter derivatives carries significant risks and is not suitable for all investors. You could lose substantially more than your initial investment. When acquiring derivative products, you have no entitlement, right or obligation to the underlying financial asset.